Magazine article from our research archive:
|
|
Report from: India
- Article from:
-
Pharmaceutical Technology
- Article date:
-
June 1, 2008
- Author:
-
|
Copyright informationCopyright Advanstar Communications, Inc. Jun 2008. Provided by ProQuest LLC. (Hide copyright information)
|
With rising drug development costs and burdensome clinical trials, Indian-based firms are transferring their research departments to other entitites in hopes of saving cash, mitigating risk, and ultimately, buying back the rewards.
Bangalore-based biotech firm Biocon is the new kid on the block with a plan to transfer its research and development (R&D) arm to a new company. Biocon is reportedly transferring all of its molecules under development into a firm that will serve as a wholly owned subsidiary.
Transferral trends
Biocon joins the list of luminaries such as Mumbai-headquartered Sun Pharma, Wockhardt, and Piramal Healthcare, and Delhi-based Ranbaxy, who have divested their R&D ...
Related newspaper, magazine, and journal articles:
|
CARACO AND SUN PHARMA SIGN LETTERS OF INTENT
PR Newswire;
July 11, 1996 ;
589 words
......relationship with Caraco will accelerate Sun Pharma's globalization, and strengthen our position...competitive, integrated pharmaceutical company, Sun Pharma's Managing Director, Dilip Shanghvi noted...plans. The proposed agreement would allow Sun Pharma and Caraco to synergize ...
|
|
Sun Pharma of India gains momentum in plan to acquire company in U.S.
Economic Times (New Delhi, India);
December 18, 2004 ;
374 words
...Dec. 18--MUMBAI, India -- Sun Pharma's plans to acquire a company...Dilip Sanghvi, the company's CMD, Sun Pharma is looking for an acquisition...further correction is expected. Sun Pharma recently issued FCCBs amounting...markets. As part of the plan, Sun Pharma is also on ...
|
|
Sun Pharma buys manufacturing ops of Hungarian firm.
Economic Times (New Delhi, India);
August 11, 2005 ;
285 words
...Aug. 11--MUMBAI, India -- Sun Pharma has acquired the raw materials and...product roll-out, Dilip Shanghvi, Sun Pharma's CMD, said in a statement. This...company's first European acquisition. Sun Pharma currently has a US subsidiary, Caraco...
|
|
Sun Pharma's Equity Ownership of Caraco to Increase to 61.
PR Newswire;
February 3, 2004 ;
599 words
......Laboratories, Ltd. announced today that Sun Pharmaceutical Industries Limited ( Sun Pharma ) has entered into an agreement...which will ultimately increase Sun Pharma's and its affiliates' equity...of this private transaction. Sun Pharma in its recent press release...increased ...
|
|
Sun Pharmaceutical Industries Ltd.: A Quarter of All-Around Strong Growth...
PR Newswire Europe;
July 28, 2008 ;
700+ words
......last year, contributing 40% of total sales. Sun Pharma holds 3.4% market share in the highly competitive...launched during the quarter. US Generics Sun Pharma continues to sell generic Protonix and Ethyol...effect on the US generic sales and profits. Sun Pharma subsidiary, Caraco ...
|
|
Sun demerges R&D to insulate core business.
Economic Times (New Delhi, India);
February 11, 2006 ;
700+ words
...Feb. 11--Sun Pharma's decision to demerge the new drug discovery...new drug delivery system, portion of its R&D business, will insulate the company...molecules could be one possibility. However, Sun Pharma's only new molecule has just completed...
|
|
Sun Pharma to buy Able Laboratories.
Times of India (New Delhi, India);
November 30, 2005 ;
247 words
......Nair-Ghaswalla Nov. 30--MUMBAI, India -- Sun Pharma has entered into an asset purchase agreement...Jersey-based Able Labs for $23.14 million. Sun Pharma maintained that the 'deal is not yet...to be in the fray, though the bid by Sun Pharma has been termed as 'the highest and best...
|
|
Tel-Aviv Court Rules in Favor of Sun Pharmaceutical; No Special Tender...
PR Newswire;
August 27, 2008 ;
700+ words
......Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced it was...yesterday rejected Taro's contention that Sun Pharma should have conducted a special tender offer under Israeli Law. As a result, Sun Pharma will be in a position to complete the...
|
|
Sun Pharma Continues Strong Performance.
PR Newswire Europe;
October 25, 2008 ;
700+ words
......increase of 19% over first half last year. Sun Pharma holds 3.4% market share in the highly...Profitable growth in a tough market Sun Pharma continues to sell generic Protonix and...on the US generic sales and profits. Sun Pharma subsidiary, Caraco Pharmaceutical Industries...
|
|
Sun buys up Israel's Taro for $454m
The Hindustan Times;
May 21, 2007 ;
378 words
......crore on Monday. The buy will catapult Sun Pharma into the major drug markets of the US...tied with Taro's brand name could give Sun Pharma an edge over its rivals like Ranbaxy...Shanghvi, chairman and managing director, Sun Pharma, told Hindustan Times. Eighty-five per...
|
|
Sun Pharmaceutical Exercises Its Options to Acquire the Shares of the...
PR Newswire;
June 25, 2008 ;
700+ words
......today announced that a subsidiary of Sun Pharma has exercised the Option under its...Limited (Taro). On May 18, 2007, Taro and Sun Pharma's subsidiaries entered into a Merger Agreement whereby Sun Pharma's subsidiary would acquire Taro, which...
|
|
Sun Pharma deal with Isreali firm Taro off
The Hindustan Times;
May 28, 2008 ;
363 words
......latter terminating the merger agreement. Sun Pharma had initiated the acquisition of Taro...applications in the US alone was to guide Sun Pharma's expansion in the US market. "In that...over termination of the acquisition. Sun Pharma's shares rose 6.61 per cent on Wednesday...
|
|
CARACO PHARMACEUTICAL MOVED TO OTC BULLETIN BOARD
PR Newswire;
July 30, 1996 ;
428 words
......capital and seek reinstatement on Nasdaq. William R. Hurd, President and Chief Operating Office of Caraco...Bulletin Board. Dilip Shanghi, the Managing Director of Sun Pharmaceutical Industries, Ltd., an Indian Company...pharmaceutical products stated: In spite of this development Sun Pharma ...
|
|
Caraco Announces Agreement
PR Newswire;
July 9, 1997 ;
407 words
......will enable Caraco to proceed with the Sun Pharma of India transactions. Upon final approval by the Reserve Bank of India (RBI), Sun Pharma has agreed to provide a cash and technology...consummated, the agreement between Caraco and Sun Pharma will enable Caraco to continue the ...
|
See all results.
Or, try our
Advanced Search.
|